Starling Oncology, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Starling Oncology, Inc. (STLN) had Deferred Tax Assets, Goodwill and Intangible Assets of $7.20 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $7.20M.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $7.39M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $7.74M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $2.53M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $7.20M 10-K · filed 2026-03-12 |
| 2024-12-31 | $7.39M 10-K · filed 2026-03-12 |
| 2023-12-31 | $7.74M 10-K · filed 2025-03-26 |
| 2022-12-31 | $2.53M 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |